EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?

Line Lundegaard Bang, Lone Wulff Madsen, Rune Micha Pedersen, Anna Christine Nilsson, Isik Somuncu Johansen, Thomas Emil Andersen

Journal of Infection and Public Health · 2024

DOI: 10.1016/j.jiph.2024.102512 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Infection and Public Health, 2024. Verfasst von Line Lundegaard Bang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Antibodies, Monoclonal, Humanized, Antibodies, Neutralizing. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Region of Southern Denmark.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19Antibodies, Monoclonal, HumanizedAntibodies, NeutralizingAntibodies, ViralAntibodies, MonoclonalHumansCOVID-19 Drug Treatment

Stichwörter der Autor:innen

COVID-19In vitro neutralizationMonoclonal antibodiesNeutralizing antibodiesSARS-CoV-2Sotrovimab

Substanzen

Antibodies, Monoclonal, HumanizedAntibodies, NeutralizingAntibodies, ViralAntibodies, Monoclonalsotrovimab

Autor:innen und Institutionen

  • Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: llbang@health.sdu.dk.
  • Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark; Unit for Infectious Diseases, Department of Medicine, Sygehus Lil…
  • Department of Clinical Microbiology, Odense University Hospital, and Research Unit of Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: rune.pedersen@rsyd.dk.
  • Department of Clinical Immunology, Odense University Hospital, and Research Unit for Clinical Immunology, University of Southern Denmark, Odense, Denmark. Electronic address: christine.nilsson@rsyd.dk.
  • Department of Infectious Diseases, Odense University Hospital and Research Unit for Infectious Diseases, University of Southern Denmark, Odense, Denmark. Electronic address: Isik.Somuncu.Johansen@rsyd.dk.
  • Department of Clinical Microbiology, Odense University Hospital, and Research Unit for Clinical Microbiology, University of Southern Denmark, Odense, Denmark. Electronic address: thandersen@health.sdu.dk.

Förderung

  • Region of Southern Denmark

Zitieren

APA

Bang, L. L., Madsen, L. W., Pedersen, R. M., Nilsson, A. C., Johansen, I. S., & Andersen, T. E. (2024). Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?. Journal of Infection and Public Health. https://doi.org/10.1016/j.jiph.2024.102512

Vancouver

Bang LL, Madsen LW, Pedersen RM, Nilsson AC, Johansen IS, Andersen TE. Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?. Journal of Infection and Public Health. 2024. doi:10.1016/j.jiph.2024.102512

BibTeX
@article{Bang2024,
  author = {Bang, Line Lundegaard and Madsen, Lone Wulff and Pedersen, Rune Micha and Nilsson, Anna Christine and Johansen, Isik Somuncu and Andersen, Thomas Emil},
  title = {Sotrovimab lost neutralization efficacy against SARS-CoV-2 subvariants but remained clinically effective: Were monoclonal antibodies against COVID-19 rejected too early?},
  journal = {Journal of Infection and Public Health},
  year = {2024},
  doi = {10.1016/j.jiph.2024.102512}
}
Kostenlos starten →